Final Results

The important market mechanism here is capital formation, not NAV. A lower upfront VCT tax incentive should pressure the marginal retail buyer first, which means slower fund-raising, weaker fee growth, and less dry powder for follow-on rounds across UK venture. That is bearish for the least self-sufficient private holdings, especially capital-intensive healthtech and pre-revenue software, where the next financing is often the valuation event.

The clean-up of quoted holdings and the buyback floor reduce downside in the wrapper itself, but they do not eliminate liquidity risk; they just stretch monetization over a longer horizon. Over 1-3 months, the market may underappreciate how a softer subscription backdrop feeds through to AUM, broker activity, and secondary-market support for small caps. Over 6-18 months, the portfolio should bifurcate: profitable, externally validated software and defense-adjacent tech can keep compounding, while cash-burning names face more punitive resets.

Consensus is likely too focused on headline dividend continuity and too little on the funding ecosystem the vehicle depends on. The contrarian setup is that the tax cut is a structural headwind for capital-dependence, but not for businesses with real product-market fit; that supports selective longs in resilient software while arguing for shorts or underweights in venture managers and the most financing-sensitive holdings. Falsifier: if 2026/27 subscriptions and secondary demand hold up despite the tax change, or if policy is revised to offset the incentive cut, the bearish flow thesis weakens quickly.